The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

Co-Chair and Moderator, James M. Foran, MD, FRCPC, and Jessica K. Altman, MD, discuss acute myeloid leukemia in this CME activity titled “The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at http://bit.ly/3EIgBTP. CME credit will be available until March 13, 2024.